The trajectory of the erectile dysfunction drug presents a intricate picture for those considering investment. While the initial introduction generated significant gains, the lapse of its intellectual property https://opensocialfactory.com/story26421602/sildenafil-and-the-pharmaceutical-industry-a-risky-opportunity